7:19
Duchenne & Becker muscular dystrophy - causes, symptoms, treatment & pathology
Osmosis from Elsevier
Overview
This video explains Duchenne and Becker muscular dystrophy, genetic disorders affecting muscle strength due to mutations in the dystrophin gene. It details the underlying pathology, how these conditions differ based on the severity of the mutation (Duchenne being more severe with complete protein loss, Becker being milder with a misshapen protein), their X-linked recessive inheritance pattern, and the resulting muscle degeneration. The summary also touches upon diagnosis, current treatment limitations, and genetic counseling.
How was this?
Save this permanently with flashcards, quizzes, and AI chat
Chapters
- Muscular dystrophy means 'bad nourishment' of muscles, leading to weakness due to degeneration within the muscle cells themselves, not nerve damage.
- It's a group of genetic disorders, with dystrophinopathies (Duchenne and Becker MD) being the most common, caused by mutations in the dystrophin gene.
- Other muscular dystrophies also exist, often involving genes that interact with the dystrophin protein complex, leading to similar symptoms.
This chapter establishes the fundamental definition and classification of muscular dystrophies, highlighting the central role of the dystrophin gene in the most common forms.
A muscle biopsy showing changes within the muscle tissue, distinguishing it from nerve damage-related weakness like neuropathies.
- Duchenne Muscular Dystrophy (DMD) results from severe mutations (like nonsense or frameshift) causing a complete loss of functional dystrophin protein, leading to severe symptoms by age 5.
- Becker Muscular Dystrophy (BMD) arises from milder mutations (like missense) that produce a misshapen but partially functional dystrophin protein, resulting in a milder form with later onset (ages 10-20).
- Both DMD and BMD are allelic disorders, meaning they stem from different mutations within the same dystrophin gene.
Understanding the difference in mutation severity explains the varying onset and progression of Duchenne and Becker muscular dystrophies, crucial for prognosis and management.
Nonsense or frameshift mutations leading to no dystrophin protein (DMD) versus missense mutations leading to a misshapen protein (BMD).
- The dystrophin gene is exceptionally large and located on the X chromosome, increasing the likelihood of mutations during reproductive cell formation.
- These disorders are X-linked recessive, making them far more common in males (XY) who have only one X chromosome and thus only one copy of the gene.
- Females (XX) can be carriers, and while typically asymptomatic due to having a second X chromosome, some may show symptoms ('manifesting carriers') if X-inactivation patterns favor the defective gene.
This explains the genetic basis and the reason for the significantly higher prevalence of these conditions in males, as well as the potential for females to be carriers or mildly affected.
A male with a defective dystrophin gene on his single X chromosome will develop the condition, while a female with a defective gene on one X chromosome might have a functional gene on her other X chromosome.
- Dystrophin protein acts as a crucial link between the muscle cell's internal structure (actin) and the external matrix, stabilizing the muscle cell membrane (sarcolemma).
- Without functional dystrophin, the sarcolemma becomes unstable, leading to leakage of cellular components like creatine kinase (CK) and influx of calcium, ultimately causing cell death.
- Chronic muscle damage leads to cycles of regeneration (resulting in varied fiber sizes) followed by atrophy, replaced by fat and scar tissue, causing progressive weakness.
This section details the molecular mechanism by which dystrophin deficiency causes muscle breakdown, explaining the cellular events leading to weakness and degeneration.
Dystrophin is compared to a large wooden support beam stabilizing a house's roof; without it, the muscle cell membrane 'wilts'.
- Common symptoms include delayed walking, waddling gait, calf pseudohypertrophy (enlarged calves due to fat/fibrous tissue), and Gowers' sign (difficulty standing up).
- Advanced symptoms can involve respiratory failure (weak diaphragm), scoliosis, heart problems (cardiomyopathy, arrhythmias), and eventual need for a wheelchair.
- Diagnosis involves elevated creatine kinase levels, genetic testing for dystrophin mutations, and muscle biopsy to assess dystrophin presence.
- Current treatments, like glucocorticoids, can slow degeneration but have side effects; physical therapy improves quality of life but doesn't cure the disease.
This covers the observable signs of the disease, how it's identified, and the current state of therapeutic interventions, emphasizing the lack of a cure.
Gowers' sign, where a child uses their hands to help push themselves up from the floor due to hip and thigh muscle weakness.
- About two-thirds of cases are inherited from a carrier mother, while one-third arise from new, spontaneous mutations.
- If a mother is a carrier, each son has a 50% chance of inheriting the mutation and developing the condition.
- Daughters of a carrier mother have a 50% chance of becoming carriers themselves, usually without significant symptoms.
Understanding the inheritance patterns is crucial for genetic counseling, allowing families to assess risks for future children and make informed decisions.
For a mother who is a carrier, 50% of her future sons will inherit the defective dystrophin gene and develop Duchenne or Becker muscular dystrophy.
Key takeaways
- Muscular dystrophies are genetic disorders characterized by progressive muscle degeneration, distinct from nerve-related weakness.
- Duchenne and Becker muscular dystrophies are caused by mutations in the dystrophin gene, differing in severity based on the degree of dystrophin protein loss.
- The large size and X-chromosome location of the dystrophin gene explain why these conditions are predominantly X-linked recessive and more common in males.
- Dystrophin protein is essential for stabilizing muscle cell membranes; its absence or dysfunction leads to cell damage, inflammation, and eventual muscle atrophy.
- While symptoms vary, they often include progressive muscle weakness, affecting mobility, respiration, and cardiac function, leading to a reduced lifespan.
- Diagnosis relies on clinical signs, elevated creatine kinase, and genetic/biopsy confirmation of dystrophin abnormalities.
- Current treatments focus on managing symptoms and slowing progression, as there is no cure for Duchenne or Becker muscular dystrophy.
- Genetic counseling is vital for families to understand inheritance risks and potential outcomes for future generations.
Key terms
Muscular DystrophyDystrophinDystrophinopathiesDuchenne Muscular Dystrophy (DMD)Becker Muscular Dystrophy (BMD)X-linked RecessiveSarcolemmaCreatine Kinase (CK)Calf PseudohypertrophyGowers' SignX-inactivation
Test your understanding
- What is the fundamental difference in the dystrophin gene mutation between Duchenne and Becker muscular dystrophy, and how does this relate to disease severity?
- Why are Duchenne and Becker muscular dystrophies considered X-linked recessive disorders, and why are they more prevalent in males?
- How does the absence or malfunction of dystrophin protein lead to muscle cell degeneration and weakness?
- What are the key diagnostic methods used to confirm Duchenne or Becker muscular dystrophy?
- What is the role of genetic counseling in families affected by these conditions?